Eight out of nine quality of life (QOL) metrics have improved or remained unchanged following initial stereotactic radiosurgery (SRS) in patients treated with 3-fraction SRS for large brain metastasis cavities, a phase I/II study has shown. Intracranial tumour progression and salvage SRS show no impact on QOL.